119 related articles for article (PubMed ID: 10942247)
1. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
[TBL] [Abstract][Full Text] [Related]
2. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
3. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
4. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
Willis TG; Jadayel DM; Du MQ; Peng H; Perry AR; Abdul-Rauf M; Price H; Karran L; Majekodunmi O; Wlodarska I; Pan L; Crook T; Hamoudi R; Isaacson PG; Dyer MJ
Cell; 1999 Jan; 96(1):35-45. PubMed ID: 9989495
[TBL] [Abstract][Full Text] [Related]
5. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
[TBL] [Abstract][Full Text] [Related]
6. BCL10 gene mutation in lymphoma.
Du MQ; Peng H; Liu H; Hamoudi RA; Diss TC; Willis TG; Ye H; Dogan A; Wotherspoon AC; Dyer MJ; Isaacson PG
Blood; 2000 Jun; 95(12):3885-90. PubMed ID: 10845924
[TBL] [Abstract][Full Text] [Related]
7. Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas.
Balakrishnan A; von Neuhoff N; Rudolph C; Kamphues K; Schraders M; Groenen P; van Krieken JH; Callet-Bauchu E; Schlegelberger B; Steinemann D
Genes Chromosomes Cancer; 2006 Oct; 45(10):883-92. PubMed ID: 16830336
[TBL] [Abstract][Full Text] [Related]
8. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors.
Kakinuma H; Habuchi T; Ito T; Mishina M; Sato K; Satoh S; Akao T; Ogawa O; Kato T
Cancer Genet Cytogenet; 2001 Apr; 126(2):134-8. PubMed ID: 11376806
[TBL] [Abstract][Full Text] [Related]
9. BCL10 somatic mutations rarely occur in gastric lymphoma: detection of high frequency of polymorphisms in BCL10 coding region.
Chen YW; Wong KY; Au WY; Liang RH; Srivastava G
Cancer Genet Cytogenet; 2001 Jun; 127(2):184-7. PubMed ID: 11425462
[TBL] [Abstract][Full Text] [Related]
10. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract][Full Text] [Related]
11. Absence of Bcl10 gene mutations in Ewing's sarcomas.
Park YK; Chi SG; Unni KK
Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
[TBL] [Abstract][Full Text] [Related]
12. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.
Tadokoro J; Nakamura Y; Furusawa S; Mitani K
Int J Hematol; 2001 Feb; 73(2):222-5. PubMed ID: 11372735
[TBL] [Abstract][Full Text] [Related]
14. Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
Takahashi H; Hosokawa Y; Suzuki R; Morishima Y; Nakamura S; Seto M
Jpn J Cancer Res; 1999 Dec; 90(12):1316-20. PubMed ID: 10665648
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
[TBL] [Abstract][Full Text] [Related]
16. Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32).
Steinemann D; Siebert R; Harder S; Martin-Subero I; Kettwig G; Hinzmann B; Gesk S; Tiemann M; Merz H; Rosenthal A; Grote W; Morris SW; Schlegelberger B
Leukemia; 2001 Mar; 15(3):474-5. PubMed ID: 11237074
[No Abstract] [Full Text] [Related]
17. Lack of BCL10 mutations in Hodgkin's disease-derived cell lines.
Re D; Benenson E; Wolf J; Diehl V; Staratschek-Jox A
Br J Haematol; 2000 May; 109(2):420-2. PubMed ID: 10848834
[TBL] [Abstract][Full Text] [Related]
18. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
20. BCL10 gene mutations rarely occur in lymphoid malignancies.
Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
